2005
DOI: 10.1016/j.bmc.2005.07.048
|View full text |Cite
|
Sign up to set email alerts
|

Optimized N-phenyl-N′-(2-chloroethyl)ureas as potential antineoplastic agents: Synthesis and growth inhibition activity

Abstract: In our ongoing research program aimed at the optimization of microtubule-self-assembly disrupting agents, we have prepared three series of phenylurea analogues (CEU), derived from N-(3-omega-hydroxyalkyl or 4-omega-hydroxyalkyl or 3-omega-hydroxyalkynyl)-phenyl-N'-(2-chloroethyl)ureas. Most compounds exhibit potent growth inhibitory activity on human colon carcinoma HT-29, human skin melanoma M21, and human breast carcinoma MCF-7 tumor cell lines, with a GI50 ranging from 250 nM to 8 microM. Among these new mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
40
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 37 publications
(43 citation statements)
references
References 27 publications
3
40
0
Order By: Relevance
“…at ASPET Journals on May 9, 2018 jpet.aspetjournals.org newly discovered CEU compound having better growth inhibition (Moreau et al, 2005). In parallel, actin fibers seem to be reduced, confirming the cytoskeletal disorganization following anti-MT treatment.…”
supporting
confidence: 53%
“…at ASPET Journals on May 9, 2018 jpet.aspetjournals.org newly discovered CEU compound having better growth inhibition (Moreau et al, 2005). In parallel, actin fibers seem to be reduced, confirming the cytoskeletal disorganization following anti-MT treatment.…”
supporting
confidence: 53%
“…The 4-iodo derivative CEU-098 is a bioisostere of the 4-tert-butyl moiety designed to improve the metabolic resistance of CEU-022 (6). Finally, CEU-236, which is a 3-(5-hydroxypentyl) substituted form of CEU, exhibits the highest cell growth inhibition capacity on several tumor cell lines (7,25).…”
Section: Resultsmentioning
confidence: 99%
“…Anti-␣-tubulin antibody (H-300) and anti-acetylated tubulin antibody (6-11B-1) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). ICEU, HPCEU, and 4ZComb-CEU were synthesized as described previously by Mounetou et al (2001), Moreau et al (2005), and Fortin et al (2007a), respectively ( Fig. 1).…”
Section: Methodsmentioning
confidence: 99%
“…These unexpected results prompted us to evaluate the effect of more potent CEUs on ␤-tubulin and microtubules. To that end, we have selected 1-(2-chloroethyl)-3-[3-(5-hydroxypentyl)phenyl]urea (HPCEU) (Moreau et al, 2005) and 1-[4-(3-hydroxy-4-methoxystyryl)phenyl]-3-(2-chloroethyl)urea (4ZCombCEU) (Fortin et al, 2007a) that either are more hydrophilic or exhibit a higher affinity to ␤-tubulin, using the original ICEU as positive control. In addition, we have also selected N,NЈ-ethylenebis-(iodoacetamide) (EBI) as control.…”
Section: Introductionmentioning
confidence: 99%